| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
126,890,000 |
| Market
Cap: |
1.15(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.79 - $9.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies for blood-related cancers where there is an unmet medical need. Co. has one commercially approved product, VONJO™ (pacritinib), which has received approval in the U.S. by the U.S. Food and Drug Administration for the treatment of adult patients with intermediate or primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 x 10^9/L.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
9,922,851 |
| Total Sell Value |
$0 |
$0 |
$0 |
$60,660,378 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
29 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Craig Adam R |
President and CEO |
• • – |
2022-07-06 |
4 |
OE |
$0.84 |
$15,327 |
D/D |
18,223 |
41,084 |
|
- |
|
| Metzger Michael A |
Director |
– • – |
2022-07-05 |
4 |
AS |
$5.98 |
$556,067 |
D/D |
(91,500) |
20,121 |
|
-5% |
|
| Metzger Michael A |
Director |
– • – |
2022-07-05 |
4 |
OE |
$0.84 |
$76,961 |
D/D |
91,500 |
111,621 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2022-07-05 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
22,861 |
|
-5% |
|
| Craig Adam R |
President and CEO |
• • – |
2022-07-05 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
49,861 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2022-07-01 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
22,861 |
|
-0% |
|
| Craig Adam R |
President and CEO |
• • – |
2022-07-01 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
49,861 |
|
- |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2022-06-30 |
4 |
A |
$2.12 |
$20,141 |
D/D |
9,516 |
16,913 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-30 |
4 |
A |
$2.12 |
$13,086 |
D/D |
6,183 |
22,861 |
|
- |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2022-06-17 |
4 |
AS |
$6.00 |
$372,505 |
D/D |
(60,000) |
7,397 |
|
-22% |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2022-06-17 |
4 |
OE |
$1.00 |
$175,000 |
D/D |
60,000 |
57,397 |
|
- |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2022-06-14 |
4 |
AS |
$5.50 |
$55,000 |
D/D |
(10,000) |
7,397 |
|
-18% |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2022-06-14 |
4 |
OE |
$0.95 |
$9,489 |
D/D |
10,000 |
17,397 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-03 |
4 |
AS |
$6.01 |
$109,520 |
D/D |
(18,223) |
16,678 |
|
-16% |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-03 |
4 |
OE |
$0.84 |
$15,327 |
D/D |
18,223 |
34,901 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-02 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
16,678 |
|
-24% |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-02 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
43,678 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-01 |
4 |
AS |
$6.00 |
$162,000 |
D/D |
(27,000) |
16,678 |
|
-14% |
|
| Craig Adam R |
President and CEO |
• • – |
2022-06-01 |
4 |
OE |
$0.84 |
$22,710 |
D/D |
27,000 |
43,678 |
|
- |
|
| Fong James K |
See RemarksOfficer |
• – – |
2022-02-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,565 |
|
269% |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2021-12-31 |
4 |
A |
$2.11 |
$3,830 |
D/D |
1,817 |
7,397 |
|
- |
|
| Craig Adam R |
President and CEO |
• • – |
2021-12-31 |
4 |
A |
$2.11 |
$6,699 |
D/D |
3,178 |
16,678 |
|
- |
|
| Seeley Bruce J. |
EVP, Chief Operating Officer |
• – – |
2021-12-31 |
4 |
A |
$2.11 |
$6,832 |
D/D |
3,241 |
43,905 |
|
- |
|
| Kirske David |
EVP, Chief Financial Officer |
• – – |
2021-06-30 |
4 |
A |
$2.13 |
$3,787 |
D/D |
1,782 |
5,580 |
|
- |
|
| Seeley Bruce J. |
EVP, Chief Operating Officer |
• – – |
2021-06-30 |
4 |
A |
$2.13 |
$6,724 |
D/D |
3,164 |
40,664 |
|
- |
|
229 Records found
|
|
Page 3 of 10 |
|
|
